Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
ID05627440

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Led by Tufts Medical Center · Updated on 2025-11-25

120

Participants Needed

2

Research Sites

30 weeks

Total Duration

On this page

Sponsors

T

Tufts Medical Center

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to study muscle loss in patients with heart failure with reduced ejection fraction (HFrEF), a condition where the heart does not pump blood effectively. It focuses on severe muscle wasting and weight loss common in these patients. The trial will explore whether increasing dietary protein intake can help reverse muscle loss, and it also examines biological pathways like GDF-15 and ActRII that may drive this muscle wasting. Participants will be randomly assigned to one of three groups receiving different levels of protein supplementation using Ensure products by Abbott Nutrition. One group receives a high dose of 30 grams protein daily (Ensure Max Protein), another a low dose of 9 grams protein daily (Ensure Original), and the third group receives no supplementation. The intervention lasts for 6 months with monitoring at 3 and 6 months. During the study, participants will have their muscle mass measured in arms and legs (appendicular lean mass) at 3 and 6 months. Additional assessments include handgrip strength, walking ability with a 6-minute walk test, and physical performance tests. Researchers will monitor protein intake and evaluate safety throughout the trial, which is sponsored by Tufts Medical Center and runs up to 2027.

CONDITIONS

Brief Title

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Left ventricular ejection fraction (LVEF) 40% or less, with NYHA class II to IV symptoms or NT-proBNP greater than 300 pg/mL
  • Age between 18 and 100 years, inclusive
  • Receiving guideline-directed medical therapy for heart failure, unless contraindicated or not tolerated
  • Presence of at least one marker of severe heart failure within the prior 12 months, such as inotropic therapy, heart failure hospitalizations, low peak oxygen consumption, limited 6-minute walk distance, significant unintentional weight loss, moderate or severe muscle wasting, or high NT-proBNP levels
Not Eligible

You will not qualify if you...

  • Pregnancy, planning to become pregnant, or women of reproductive potential unwilling to complete pregnancy testing before randomization
  • History of left ventricular assist device, heart transplantation, or severe kidney impairment (eGFR less than 20 mL/min/1.73 m2)
  • Known clinical disorders causing muscle weakness or wasting such as muscular dystrophy, mitochondrial disorders, active cancer, or severe post-stroke disability
  • Allergies or intolerances to milk, protein, lactose, or galactose
  • Weight over 350 pounds or body mass index over 40 kg/m2
  • Recent or planned use of obesity-dosed GLP-1 or GIP/GLP-1 agonist medications within specified timeframes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 months

Participants receive daily protein supplementation with either Ensure Max Protein, Ensure Original, or no supplementation to support muscle recovery in heart failure.

Visits at 3 months and 6 months for assessments

Trial Site Locations

Total: 2 locations

1

Tufts Medical Center

Boston, Massachusetts, United States, 02111

Actively Recruiting

2

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

A

Amanda R Vest, MBBS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Similar Trials

Extensive Post-discharge Counselling and Phone-based Follow-...

Heart Failure

Actively Recruiting

1 location

Three-Dimensional Assessment of Right Ventricular Function i...

Heart Failure

Actively Recruiting

1 location

Myocardial Fibrosis in Heart Failure: A Pilot Study Using 68...

Myocardial Fibrosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here